Cargando…
Incidence and risk factors associated with development of clinical cardiotoxicity in dogs receiving doxorubicin
BACKGROUND: Doxorubicin (DOX) can cause cumulative cardiotoxicity in dogs, but the incidence of clinical cardiotoxicity in dogs receiving DOX has not been determined. HYPOTHESIS/OBJECTIVES: To determine if the duration of DOX infusion influences the incidence of cardiotoxicity, to characterize the i...
Autores principales: | Hallman, Briana E., Hauck, Marlene L., Williams, Laurel E., Hess, Paul R., Suter, Steven E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430885/ https://www.ncbi.nlm.nih.gov/pubmed/30697816 http://dx.doi.org/10.1111/jvim.15414 |
Ejemplares similares
-
Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin‐induced cardiotoxicity
por: Beaumier, Amelie, et al.
Publicado: (2020) -
Clinical features and outcomes in 38 dogs with cholelithiasis receiving conservative or surgical management
por: Allan, Frederik, et al.
Publicado: (2021) -
Expression of Apoptosis‐regulating Proteins Bcl‐2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma
por: Meichner, K., et al.
Publicado: (2016) -
Risk factors associated with progressive increases in serum creatinine concentrations in cats with cancer receiving doxorubicin
por: Kopecny, Lucy, et al.
Publicado: (2020) -
Blood Transfusions in Dogs and Cats Receiving Hemodialysis: 230 Cases (June 1997–September 2012)
por: Langston, C., et al.
Publicado: (2017)